pharmaphorum retweeted
Hurrah to @WeRAnthem and @AstellasEurope - such a great campaign
And taking home their first gold of the night is Break Free From Plans to Pee for @AstellasEurope by Anthem PR and the Good Ideas Group #PMSocietyAwards
pharmaphorum retweeted
Screening at #prenatal, in infancy, and over 40 - it makes the world of difference, McCulloch says. Ben Wiegand reverts the conversation to #obesity and #diabetes. In Finland, 1 in 70 have diabetes. #WorldWithoutDisease Summit @pharmaphorum
pharmaphorum retweeted
Ben Wiegand, founding partner of #CWWDA takes to the stage with Laura McCulloch, medical advisor at CWWDA and general practitioner at the #NHS #WorldWithoutDisease @pharmaphorum
pharmaphorum retweeted
Moving on now to assessment of partnering during times of instability at @EBDgroup’s #bioeuropespring - how to weather the storm and whether optimism shines a ray still as regards innovation.
pharmaphorum retweeted
To follow on, discussion of the future of #APAC partnering on Day Two on @EBDgroup’s #bioeuropespring
pharmaphorum retweeted
The #obesity marketplace being discussed at @EBDgroup’s #bioeuropespring, with Resalis Therapeutics and EraCal Therapeutics
pharmaphorum retweeted
Replying to @pharmaphorum
@pharmaphorum is on site at @EBDgroup’s second day of #bioeuropespring - do drop a line during the day if you’re seeking media opportunities. Now, to start the day: the new wave of #cellandgenetherapy…
pharmaphorum retweeted
Listening to Nature Biotechnology’s Melanie Senior at @EBDgroup’s #bioeuropespring joined by Roche’s James Sabry and Novartis’ Susanna Kreutz. #partnerships between #pharma and #biotechs
pharmaphorum retweeted
At @EBDgroup’s #bioeuropespring Anna Chrisman and BIO’s David Thomas opened the day, discussing the event’s 17th anniversary and recent worrying trends and happenings…
pharmaphorum retweeted
Replying to @pharmaphorum
pharmaphorum retweeted
Our valued media partner @pharmaphorum has launched its new website and wants to hear from you!
As part of its continued commitment to delivering high-quality content, the editorial team invites you to participate in the following #readerssurvey pharmaphorum.com/news/we-wan…
pharmaphorum retweeted
To close this insightful day at #PharmaIntegrates, a fascinating - and rather lively - discussion of #AI. Hope, hype, or happening? Panel including #IncubateBioLtd, #WhiteSwan, and #JessicaMorley, this was one not to be missed!
pharmaphorum retweeted
A key talk of the day: tackling The Big ‘C’ - #cancer R&D and #oncology developments with @StartCodon, @Cyted_UK, and others; seeking how best to treat human patients, and not just cure mice…
pharmaphorum retweeted
Discussing #diversity, #equity, and #inclusion - including #neurodiversity - and generally embracing difference in #pharma with @TakedaPharma, @Pfizer_UK and others.
pharmaphorum retweeted
Looking back at today’s #PharmaIntegrates event, with Lord @jamesosh and panel on The Rise of the #Centenarians and the #health and #care issues that come with such longer #lifespans - or what should be #healthspans
pharmaphorum retweeted
A fireside chat with Lord David Prior and Tamsin Berry at #pharmaintegrates 2022 #London, discussing #precisionpublichealth
pharmaphorum retweeted
And @pharmaphorum is on site in the City of #London for LSI’s #PharmaIntegrates 2022 this wet and windy Thursday in November.
pharmaphorum retweeted
As @TheEconomist #WorldCancerSeriesEurope continues into Day Two, a reminder of yesterday’s closing panel on moving #genomics up the priority list, with Parker Moss of @GenomicsEngland moderating.
pharmaphorum retweeted
Discussion of novel #biomarkers and changing #patientoutcomes in #oncology with Sarah Moseley of @GrailBio and Francesco Lorenzo of #EuropeanCancerPatientCoalition, as well as #HealthValueAlliance moderator, Matthew Hickey, and Professor Neil Ryan.
pharmaphorum retweeted
Post-lunch panel discussion centred on increasing speed, #accessibility and effectiveness of #screening, including @WorldBladderCan and @AgeasGroup, and #iDNA work with #lungcancer : 75% of cancer cases are not subject to screening


















